Harnessing RNA base editing for diverse applications in RNA biology and RNA therapeutics

Abstract

Recent advancements in molecular engineering have established RNA-based technologies as powerful tools for both fundamental research and translational applications. Among the various RNA-based technologies developed, RNA base editing has recently emerged as a groundbreaking advancement. It primarily involves the conversion of adenosine (A) to inosine (I) and cytidine (C) to uridine (U), which are mediated by ADAR and APOBEC enzymes, respectively. RNA base editing has been applied in both biological research and therapeutic contexts. It enables site-directed editing within target transcripts, offering reversible, dose-dependent effects, in contrast to the permanent or heritable changes associated with DNA base editing. Additionally, RNA editing-based profiling of RNA-binding protein (RBP) binding sites facilitates transcriptome-wide mapping of RBP-RNA interactions in specific tissues and at the single-cell level. Furthermore, RNA editing-based sensors have been utilized to express effector proteins in response to specific RNA species. As RNA base editing technologies continue to evolve, we anticipate that they will significantly drive advancements in RNA therapeutics, synthetic biology, and biological research.

Keywords

RNA editing / ADAR / APOBEC / RNA sensing / Base editing / RNA binding protein / Biological Sciences / Biochemistry and Cell Biology / Genetics

References

[1] AbudayyehOO, et al. . C2c2 is a single-component programmable RNA-guided RNA-targeting CRISPR effector. Science, 2016, 353: aaf5573.

[2] AbudayyehOO, et al. . RNA targeting with CRISPR-Cas13. Nature, 2017, 550: 280-284.

[3] AzadMTA, BhaktaS, TsukaharaT. Site-directed RNA editing by adenosine deaminase acting on RNA for correction of the genetic code in gene therapy. Gene Ther, 2017, 24: 779-786.

[4] BhaktaS, AzadMTA, TsukaharaT. Genetic code restoration by artificial RNA editing of Ochre stop codon with ADAR1 deaminase. Protein Eng Des Sel, 2018, 31: 471-478.

[5] BoothBJ, et al. . RNA editing: expanding the potential of RNA therapeutics. Mol Ther, 2023, 31: 1533-1549.

[6] BrannanKW, et al. . Robust single-cell discovery of RNA targets of RNA-binding proteins and ribosomes. Nat Methods, 2021, 18: 507-519.

[7] CoxDBT, et al. . RNA editing with CRISPR-Cas13. Science, 2017, 358: 1019-1027.

[8] Diaz QuirozJF, SiskelLD, RosenthalJJC. Site-directed A → I RNA editing as a therapeutic tool: moving beyond genetic mutations. RNA, 2023, 29: 498-505.

[9] East-SeletskyA, et al. . Two distinct RNase activities of CRISPR-C2c2 enable guide-RNA processing and RNA detection. Nature, 2016, 538: 270-273.

[10] EisenbergE. Bioinformatic approaches for accurate assessment of A-to-I editing in complete transcriptomes. Methods Enzymol, 2025, 710: 241-265.

[11] EisenbergE, LevanonEY. A-to-I RNA editing - immune protector and transcriptome diversifier. Nat Rev Genet, 2018, 19: 473-490.

[12] ElmentaiteR, Dominguez CondeC, YangL, TeichmannSA. Single-cell atlases: shared and tissue-specific cell types across human organs. Nat Rev Genet, 2022, 23: 395-410.

[13] ErionDM, LiuLY, BrownCR, RennardS, FarahH. Editing approaches to treat alpha-1 antitrypsin deficiency. Chest, 2025, 167: 444-452.

[14] GagnidzeK, Rayon-EstradaV, HarrochS, BullochK, PapavasiliouFN. A new chapter in genetic medicine: RNA editing and its role in disease pathogenesis. Trends Mol Med, 2018, 24: 294-303.

[15] GebauerF, SchwarzlT, ValcarcelJ, HentzeMW. RNA-binding proteins in human genetic disease. Nat Rev Genet, 2021, 22: 185-198.

[16] GerstbergerS, HafnerM, TuschlT. A census of human RNA-binding proteins. Nat Rev Genet, 2014, 15: 829-845.

[17] GoldA, LevanonEY, EisenbergE. The new RNA-editing era – ethical considerations. Trends Genet, 2021, 37: 685-687.

[18] GottJM, EmesonRB. Functions and mechanisms of RNA editing. Annu Rev Genet, 2000, 34: 499-531.

[19] HafnerM, et al. . Transcriptome-wide Identification of RNA-Binding Protein and MicroRNA Target Sites by PAR-CLIP. Cell, 2010, 141: 129-141.

[20] HanWJ, et al. . Programmable RNA base editing with a single gRNA-free enzyme. Nucleic Acids Res, 2022, 50: 9580-9595.

[21] HuangX, et al. . Programmable C-to-U RNA editing using the human APOBEC3A deaminase. EMBO J, 2020, 39: e104741.

[22] JiangKY, et al. . Programmable eukaryotic protein synthesis with RNA sensors by harnessing ADAR. Nat Biotechnol, 2023, 41: 698-707.

[23] KaseniitKE, et al. . Modular, programmable RNA sensing using ADAR editing in living cells (vol 41, pg 482, 2023). Nat Biotechnol, 2023, 41: 577-577.

[24] KatrekarD, et al. . Efficient in vitro and in vivo RNA editing via recruitment of endogenous ADARs using circular guide RNAs. Nat Biotechnol, 2022, 40: 938-945.

[25] KönigJ, et al. . iCLIP reveals the function of hnRNP particles in splicing at individual nucleotide resolution. Nat Struct Mol Biol, 2010, 17: 909-U166.

[26] LanTH, HeL, HuangY, ZhouY. Optogenetics for transcriptional programming and genetic engineering. Trends Genet, 2022, 38: 1253-1270.

[27] LiJB, ChurchGM. Deciphering the functions and regulation of brain-enriched A-to-I RNA editing. Nat Neurosci, 2013, 16: 1518-1522.

[28] LiL, et al. . The landscape of miRNA editing in animals and its impact on miRNA biogenesis and targeting. Genome Res, 2018, 28: 132-143.

[29] LicatalosiDD, et al. . HITS-CLIP yields genome-wide insights into brain alternative RNA processing. Nature, 2008, 456: 464-U422.

[30] LongoSK, GuoMG, JiAL, KhavariPA. Integrating single-cell and spatial transcriptomics to elucidate intercellular tissue dynamics. Nat Rev Genet, 2021, 22: 627-644.

[31] McMahonAC, et al. . TRIBE: Hijacking an RNA-Editing Enzyme to Identify Cell-Specific Targets of RNA-Binding Proteins. Cell, 2016, 165: 742-753.

[32] MerkleT, et al. . Precise RNA editing by recruiting endogenous ADARs with antisense oligonucleotides. Nat Biotechnol, 2019, 37: 133-138.

[33] MeyerKD. DART-seq: an antibody-free method for global m6A detection. Nat Methods, 2019, 16: 1275-1280.

[34] MonianP, et al. . Endogenous ADAR-mediated RNA editing in non-human primates using stereopure chemically modified oligonucleotides. Nat Biotechnol, 2022, 40: 1093-1120.

[35] Montiel-GonzalezMF, Vallecillo-ViejoI, YudowskiGA, RosenthalJJC. Correction of mutations within the cystic fibrosis transmembrane conductance regulator by site-directed RNA editing. Proc Natl Acad Sci USA, 2013, 110: 18285-18290.

[36] PaunovskaK, LoughreyD, DahlmanJE. Drug delivery systems for RNA therapeutics. Nat Rev Genet, 2022, 23: 265-280.

[37] PecoriR, Di GiorgioS, Paulo LorenzoJ, NinaPapavasiliou F. Functions and consequences of AID/APOBEC-mediated DNA and RNA deamination. Nat Rev Genet, 2022, 23: 505-518.

[38] PfeifferLS, StafforstT. Precision RNA base editing with engineered and endogenous effectors. Nat Biotechnol, 2023, 41: 1526-1542.

[39] PiweckaM, RajewskyN, Rybak-WolfA. Single-cell and spatial transcriptomics: deciphering brain complexity in health and disease. Nat Rev Neurol, 2023, 19: 346-362.

[40] PortoEM, KomorAC, SlaymakerIM, YeoGW. Base editing: advances and therapeutic opportunities. Nat Rev Drug Discov, 2020, 19: 839-859.

[41] QianY, et al. . Programmable RNA sensing for cell monitoring and manipulation. Nature, 2022, 610: 713-721.

[42] QuL, et al. . Programmable RNA editing by recruiting endogenous ADAR using engineered RNAs. Nat Biotechnol, 2019, 37: 1059-1069.

[43] RahmanR, XuWJ, JinH, RosbashM. Identification of RNA-binding protein targets with HyperTRIBE. Nat Protoc, 2018, 13: 1829-1849.

[44] RamaswamiG, et al. . Accurate identification of human Alu and non-Alu RNA editing sites. Nat Methods, 2012, 9: 579-581.

[45] RamaswamiG, et al. . Identifying RNA editing sites using RNA sequencing data alone. Nat Methods, 2013, 10: 128-132.

[46] ReautschnigP, et al. . CLUSTER guide RNAs enable precise and efficient RNA editing with endogenous ADAR enzymes in vivo. Nat Biotechnol, 2022, 40: 759-768.

[47] Reautschnig P, et al. Precise in vivo RNA base editing with a wobble-enhanced circular CLUSTER guide RNA. Nat Biotechnol. 2024. https://doi.org/10.1038/s41587-024-02313-0.

[48] RuanXB, HuKN, ZhangXC. PIE-seq: identifying RNA-binding protein targets by dual RNA-deaminase editing and sequencing. Nat Commun, 2023, 14: 3275.

[49] SongY, et al. . irCLASH reveals RNA substrates recognized by human ADARs. Nat Struct Mol Biol, 2020, 27: 351-362.

[50] SongJ, ZhuangY, YiC. Programmable RNA base editing via targeted modifications. Nat Chem Biol, 2024, 20: 277-290.

[51] SpitzerJ, et al. . PAR-CLIP (Photoactivatable Ribonucleoside-Enhanced Crosslinking and Immunoprecipitation): a Step-By-Step Protocol to the Transcriptome-Wide Identification of Binding Sites of RNA-Binding Proteins. Method Enzymol, 2014, 539: 113-161.

[52] StafforstT, SchneiderMF. An RNA-deaminase conjugate selectively repairs point mutations. Angew Chem Int Edit, 2012, 51: 11166-11169.

[53] Sun YF, et al. Improved RNA base editing with guide RNAs mimicking highly edited endogenous ADAR substrates. Nat Biotechnol. 2025. https://doi.org/10.1038/s41587-025-02628-6.

[54] TaoJL, BauerDE, ChiarleR. Assessing and advancing the safety of CRISPR-Cas tools: from DNA to RNA editing. Nat Commun, 2023, 14: 212.

[55] UleJ, et al. . CLIP identifies Nova-regulated RNA networks in the brain. Science, 2003, 302: 1212-1215.

[56] VogelP, StafforstT. Critical review on engineering deaminases for site-directed RNA editing. Curr Opin Biotech, 2019, 55: 74-80.

[57] VogelP, SchneiderMF, WettengelJ, StafforstT. Improving Site-Directed RNA Editing In Vitro and in Cell Culture by Chemical Modification of the GuideRNA. Angew Chem Int Edit, 2014, 53: 6267-6271.

[58] WangM, OgeL, Perez-GarciaMD, HamamaL, SakrS. The PUF Protein Family: Overview on PUF RNA Targets, Biological Functions, and Post Transcriptional Regulation. Int J Mol Sci, 2018, 19: 410.

[59] WoolfTM, ChaseJM, StinchcombDT. Toward the therapeutic editing of mutated RNA sequences. Proc Natl Acad Sci U S A, 1995, 92: 8298-8302.

[60] XiangJS, SchaferDM, RothamelKL, YeoGW. Decoding protein-RNA interactions using CLIP-based methodologies. Nat Rev Genet, 2024, 25: 879-895.

[61] XieZ, WroblewskaL, ProchazkaL, WeissR, BenensonY. Multi-input RNAi-based logic circuit for identification of specific cancer cells. Science, 2011, 333: 1307-1311.

[62] YiZ, et al. . Engineered circular ADAR-recruiting RNAs increase the efficiency and fidelity of RNA editing in vitro and in vivo. Nat Biotechnol, 2022, 40: 946-955.

[63] ZhangR, et al. . Quantifying RNA allelic ratios by microfluidic multiplex PCR and sequencing. Nat Methods, 2014, 11: 51-54.

[64] ZhangX, et al. . Engineered circular guide RNAs boost CRISPR/Cas12a-and CRISPR/Cas13d-based DNA and RNA editing. Genome Biol, 2023, 24: 145.

[65] ZhaoEM, et al. . RNA-responsive elements for eukaryotic translational control. Nat Biotechnol, 2022, 40: 539-545.

Funding

National Key R&D Program of China(2024YFC3405900)

RIGHTS & PERMISSIONS

The Author(s)